Haloperidol Tablet
Product Images NDC 55154-5059

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 55154-5059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

4d9d027a 1ed4 4079 Ba74 A01380b0f0a2 00

4d9d027a 1ed4 4079 Ba74 A01380b0f0a2 00
This is the label of a medication called Haloperidol tablets. The tablets come in blister packaging that contains 10 tablets. Each tablet contains Haloperidol, USP § mg. The dosage instructions are not given on the label and must be obtained through the prescribing information. The medication should be stored at 20°C to 25°C (68°F to 77°F), and protected from light. The label includes a warning that the Unit Dose package is not child-resistant and is intended for institutional use only. The medication is manufactured by Mylan Pharmaceuticals Inc. in Morgantown, WV and distributed by Wiytan Institutional Inc. in Rockford, IL. The label also includes contact information for Mylan and Cardinal Health.*
FDA Label Image

Structural Formula (B4a0c347 0c03 4cfc B6fd 79fc18bc85f4 01)

Structural Formula (B4a0c347 0c03 4cfc B6fd 79fc18bc85f4 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.